134 related articles for article (PubMed ID: 25203779)
1. Novel sulfonyl(thio)urea derivatives act efficiently both as insulin secretagogues and as insulinomimetic compounds.
Mascarello A; Frederico MJ; Castro AJ; Mendes CP; Dutra MF; Woehl VM; Yunes RA; Mena Barreto Silva FR; Nunes RJ
Eur J Med Chem; 2014 Oct; 86():491-501. PubMed ID: 25203779
[TBL] [Abstract][Full Text] [Related]
2. A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agen.
Sugawara K; Honda K; Reien Y; Yokoi N; Seki C; Takahashi H; Minami K; Mori I; Matsumoto A; Nakaya H; Seino S
PLoS One; 2016; 11(10):e0164785. PubMed ID: 27764176
[TBL] [Abstract][Full Text] [Related]
3. [Derivatives of 2-mercaptobenzenesulphonylamide. IV. Synthesis and properties of some hypoglycemic agents derived from N-(4-chloro-2-mercapto-5-methylbenzenesulphonyl)urea].
Brzozowski Z; Wójcikowski C
Acta Pol Pharm; 1990; 47(3-4):45-8. PubMed ID: 12959242
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and hyperglycemic, biochemical and histopathological evaluation of novel sulfonylbiguanide and sulfonylurea derivatives as potent anti-diabetic agents.
Basyouni WM; Abbas SY; El-Bayouki KAM; Younis EA; Ali SA; Aly HF
Bioorg Chem; 2021 Dec; 117():105418. PubMed ID: 34736133
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of Action of Novel Glibenclamide Derivatives on Potassium and Calcium Channels for Insulin Secretion.
Frederico MJS; Castro AJG; Menegaz D; Murat CB; Mendes CP; Mascarello A; Nunes RJ; Silva FRMB
Curr Drug Targets; 2017; 18(6):641-650. PubMed ID: 27316908
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of glibenclamide on metabolic parameters, GLUT1 expression, and liver injury in rats with severe and mild streptozotocin-induced diabetes mellitus.
Sokolovska J; Isajevs S; Sugoka O; Sharipova J; Paramonova N; Isajeva D; Rostoka E; Sjakste T; Kalvinsh I; Sjakste N
Medicina (Kaunas); 2012; 48(10):532-43. PubMed ID: 23324250
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of action of ursolic acid as insulin secretagogue and insulinomimetic is mediated by cross-talk between calcium and kinases to regulate glucose balance.
Castro AJ; Frederico MJ; Cazarolli LH; Mendes CP; Bretanha LC; Schmidt ÉC; Bouzon ZL; de Medeiros Pinto VA; da Fonte Ramos C; Pizzolatti MG; Silva FR
Biochim Biophys Acta; 2015 Jan; 1850(1):51-61. PubMed ID: 25312987
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and blood glucose lowering effect of novel pyridazinone substituted benzenesulfonylurea derivatives.
Rathish IG; Javed K; Bano S; Ahmad S; Alam MS; Pillai KK
Eur J Med Chem; 2009 Jun; 44(6):2673-8. PubMed ID: 19171410
[TBL] [Abstract][Full Text] [Related]
9. [Progress in studies on antidiabetic agents].
Tang L; Yang YS; Ji RY
Yao Xue Xue Bao; 2001 Sep; 36(9):711-5. PubMed ID: 12580115
[No Abstract] [Full Text] [Related]
10. Antidiabetic effect of novel benzenesulfonylureas as PPAR-γ agonists and their anticancer effect.
Kharbanda C; Alam MS; Hamid H; Javed K; Dhulap A; Bano S; Ali Y
Bioorg Med Chem Lett; 2015 Oct; 25(20):4601-5. PubMed ID: 26384286
[TBL] [Abstract][Full Text] [Related]
11. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
Clark HE; Matthews DR
Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structural characterization and in vivo anti-diabetic evaluation of some new sulfonylurea derivatives in normal and silicate coated nanoparticle forms as anti-hyperglycemic agents.
Sroor FM; Abbas SY; Basyouni WM; El-Bayouki KAM; El-Mansy MF; Aly HF; Ali SA; Arafa AF; Haroun AA
Bioorg Chem; 2019 Nov; 92():103290. PubMed ID: 31561109
[TBL] [Abstract][Full Text] [Related]
13. Incretinomimetic and Insulinomimetic Effect of (2E)-N'-(1'-Naphthyl)-3,4,5-Trimethoxybenzohydrazide for Glycemic Homeostasis.
Frederico MJ; Mascarello A; Castro AJ; Da Luz G; Altenhofen D; Mendes CP; Leal PC; Yunes RA; Nunes RJ; Silva FR
J Cell Biochem; 2016 May; 117(5):1199-209. PubMed ID: 26447772
[TBL] [Abstract][Full Text] [Related]
14. Effect of 1-[4- [2-(4-bromobenzenesulfonamino) ethyl] phenylsulfonyl]-3-(trans-4-methylcyclohexyl)urea (I4), a new synthetic sulfonylurea compound, on glucose metabolism in vivo and in vitro.
Wu GZ; Hong G; Zhang WP; Zhang HB
Arzneimittelforschung; 2009; 59(11):550-6. PubMed ID: 20066963
[TBL] [Abstract][Full Text] [Related]
15. New Quinazoline-Sulfonylurea Conjugates: Design, Synthesis and Hypoglycemic Activity.
Abou-Seri SM; Taha AM; Mohamed MA; Abdelkader NM
Med Chem; 2019 Aug; 15(6):634-647. PubMed ID: 30526467
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis and in Vivo Evaluation of Novel Glycosylated Sulfonylureas as Antihyperglycemic Agents.
Suaifan GA; Shehadeh MB; Darwish RM; Al-Ijel H; Abbate V
Molecules; 2015 Nov; 20(11):20063-78. PubMed ID: 26561797
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of phthalimide-sulfonylurea hybrids as PPARγ and SUR agonists.
El-Zahabi MA; Elbendary ER; Bamanie FH; Radwan MF; Ghareib SA; Eissa IH
Bioorg Chem; 2019 Oct; 91():103115. PubMed ID: 31310882
[TBL] [Abstract][Full Text] [Related]
18. Molecular Docking, Synthesis and Biological Evaluation of Sulphonylureas/ Guanidine Derivatives as Promising Antidiabetic Agent.
Panchal II; Sen DJ; Patel AD; Shah U; Patel M; Navale A; Bhavsar V
Curr Drug Discov Technol; 2018; 15(4):315-325. PubMed ID: 28969569
[TBL] [Abstract][Full Text] [Related]
19. [40 years of using sulfonylurea derivatives for treatment of diabetes].
Sieradzki J
Przegl Lek; 1996; 53(9):641-6. PubMed ID: 8992529
[TBL] [Abstract][Full Text] [Related]
20. Cooperation between cAMP signalling and sulfonylurea in insulin secretion.
Shibasaki T; Takahashi T; Takahashi H; Seino S
Diabetes Obes Metab; 2014 Sep; 16 Suppl 1():118-25. PubMed ID: 25200305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
